You have 9 free searches left this month | for more free features.

Condition

Melanoma (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Millennium Pharmaceuticals, Inc. (1)

Collaborator

Intervention

ipilimumab (1)

nivolumab (1)

tak-202 (1)

tak-580 (1)

vedolizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

tak-580

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma Trial in United States (TAK-580, TAK-202, vedolizumab)

Terminated

Melanoma

TAK-580
+4 more

Tucson, Arizona
+13 more

Mar 3, 2021